期刊文献+

Rare leptin in non-alcoholic fatty liver cirrhosis:A case report

下载PDF
导出
摘要 BACKGROUND Non-alcoholic fatty liver disease(NAFLD)-related cirrhosis is mainly caused by NAFLD by causing inflammation which leads to fibrosis.The role of leptin in NAFLD-related cirrhosis has been rarely reported.CASE SUMMARY This study presents the case of a 65-year-old male patient who was referred to The First Affiliated Hospital of Guangxi University of Chinese Medicine,Guangxi,Chi-na,for diagnosis and treatment for liver cirrhosis.Initially,the cause of liver cirrhosis was unknown.After radiology,laboratory examination,pathological results and analysis of the patient’s signs and symptoms,the case was finally diagnosed with final NAFLD-related cirrhosis.Although this study reports a single case,the findings might expand the understanding of leptin’s role in NAFLD-related cirrhosis and might provide a basis for the clinical diagnostic criteria,pathological features and treatment of NAFLD-related cirrhosis.CONCLUSION Although the occurrence of marasmus NAFLD-related cirrhosis is rare,it needs to be distinguished from other liver diseases,including viral hepatitis,drug-induced liver disease,Wilson’s disease and autoimmune liver disease.Aggressive treatment is needed to prevent the progression of NAFLD-related cirrhosis.
出处 《World Journal of Clinical Cases》 SCIE 2022年第28期10293-10300,共8页 世界临床病例杂志
基金 Supported by Guangxi Provincial Natural Science Foundation of China,No.2022GXNSFBA035485 and No.2022GXNSFAA035460 Basic Ability Improvement Project of Young and Middle-aged Teachers in Guangxi Colleges and Universities,No.2019KY0313 the National Natural Science Foundation of China,No.81760845 and No.81403382 Innovation Project of Guangxi Graduate Education,No.YCSW2021220 and No.YCXJ2021056。
  • 相关文献

参考文献1

二级参考文献21

  • 1McAllister EJ,Dhurandhar NV,Keith SW,Aronne LJ,Barg- er J,Baskin M,Benca RM,Biggio J,Boggiano MM,Eisen- mann JC,Elobeid M,Fontaine KR,Gluckman P,Hanlon EC,Katzmarzyk P,Pietrobelli A,Redden DT,Ruden DM,Wang C,Waterland RA,Wright SM,Allison DB.Ten putative con- tributors to the obesity epidemic. Critical Reviews in Food Science and Nutrition . 2009
  • 2Daskalopoulou SS,Mikhailidis DP,Elisaf M.Prevention and treatment of the metabolic syndrome. Angiology . 2004
  • 3ISMAIL M H.Nonalcoholic fatty liver disease andtype 2 diabetes mellitus:the hidden epidemic. The American Journal of The Medical Sciences . 2011
  • 4Grundy SM,Cleeman JI,Merz CN,et al.Implications of recent clinical trials for the national cholesterol education program adult treatment panel III guidelines. Circulation . 2004
  • 5TM Leung,GL Tipoe,EC Liong,TY Lau,ML Fung,AA Nanji.Endothelial nitric oxide synthase is a critical factor in experimental liver fibrosis. International Journal of Experimental Pathology . 2008
  • 6AT Taher,KM Musallam,A Inati.Iron overload: consequences, assessment, and monitoring. Hemoglobin . 2009
  • 7Yilmaz Y.NAFLD in the absence of metabolic syndrome:differentepidemiology,pathogenetic mechanisms,risk factors for disease progres-sion?. Seminars in Liver Disease . 2012
  • 8Kassi E,Pervanidou P,Kaltsas G,et al.Metabolic syn-drome:definitions and controversies. BMC Med . 2011
  • 9Cohen JC,Horton JD,Hobbs HH.Human fatty liver dis-ease:old questions and new insights. Science . 2011
  • 10Vanni E,Bugianesi E,Kotronen A,De Minicis S,Yki-Jrvin-en H,Svegliati-Baroni G.From the metabolic syndrome to NAFLD or vice versa. Digestive and Liver Disease . 2010

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部